Biogen: Innovative Therapies for Serious Diseases

Biogen is a global biotechnology company that focuses on discovering, developing, and delivering innovative therapies to transform the lives of patients with serious diseases. The company was founded in 1980 and is headquartered in Cambridge, Massachusetts. Biogen's mission is to harness the power of science to discover new medicines that address some of the world's most pressing medical needs.

Biogen's product portfolio includes several approved therapies for various diseases, including multiple sclerosis, spinal muscular atrophy, and hemophilia. The company also has a robust pipeline of investigational therapies in various stages of development, targeting a range of diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Biogen's focus on innovation and scientific excellence has led to numerous breakthroughs in the field of biotechnology. The company has been recognized for its commitment to improving patient lives and has received numerous awards and accolades for its work.